Use of the Kidney Failure Risk Equation to reduce uncertainty in predicting time to ESRD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Referral patterns, disease progression and impact of the kidney failure risk equation (KFRE) in a Queensland Chronic Kidney Disease Registry (CKD.QLD) cohort: a study protocol.BMJ open · 2022
   Article
2. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.BMC nephrology · 2021
   Article
3. Risk-Based Triage for Nephrology Referrals Using the Kidney Failure Risk Equation.Canadian journal of kidney health and disease · 2017
   Article

Corrections and comments

• Comment on
  Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).2015

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as